Stock A217480 SD BIOTECHNOLOGIES CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

News SD Biotechnologies Co., Ltd.

Equities

A217480

KR7217480003

End-of-day quote Korea S.E.
Other stock markets
 23:00:00 21/03/2023 GMT 		5-day change 1st Jan Change
500 KRW -4.90% Intraday chart for SD Biotechnologies Co., Ltd. +0.00% +0.00%
2023 SD Biotechnologies Co., Ltd. cancelled the transaction announced on January 26, 2023 CI
2023 SD Biotechnologies Co., Ltd. announced that it has received KRW 20 billion in funding from Sangsangin Investment & Securities Co.,Ltd. CI

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
SD Biotechnologies Co., Ltd. cancelled the transaction announced on January 26, 2023
CI
SD Biotechnologies Co., Ltd. announced that it has received KRW 20 billion in funding from Sangsangin Investment & Securities Co.,Ltd.
CI
SD Biotechnologies Co., Ltd. announced that it expects to receive KRW 11.999999918 billion in funding
CI
SD Biotechnologies Co., Ltd. agreed to acquire a 38.636208% stake in IMMUNOBIOTECH Corp. from KOSSEN Co., Ltd. for KRW 5.3 billion.
CI
SD Biotechnologies to Raise $27 Million From Share Sale; Shares Slump 23%
MT
SD Biotechnologies Co., Ltd. Auditor Raises 'Going Concern' Doubt
CI
SD Biotechnologies Co., Ltd. announced that it has received KRW 17 billion in funding from BNK Securities Co., Ltd.
CI
SD Biotechnologies Co., Ltd. announced that it expects to receive KRW 17000 billion in funding from BNK Securities Co., Ltd. and other investors
CI
SD Biotechnologies Co., Ltd. announced that it has received KRW 21 billion in funding from Leading Investment & Securities Co., Investment Arm, EBEST Investment & Securities Co., Ltd.
CI
SD Biotechnologies Co., Ltd. announced that it expects to receive KRW 21 billion in funding from Leading Investment & Securities Co., Investment Arm, EBEST Investment & Securities Co., Ltd.
CI
SD Biotechnologies Co., Ltd. cancelled the acquisition of remaining 5.59% stake in Alpha B&H Co.,Ltd.
CI
SD Biotechnologies Co., Ltd. agreed to acquire remaining 5.59% stake in Alpha B&H Co.,Ltd for KRW 45.7 million.
CI
SD Biotechnologies Co., Ltd. has completed an IPO in the amount of KRW 57.6 billion.
CI
SD Biotechnologies Co., Ltd. has filed an IPO.
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. A217480 Stock
  4. News SD Biotechnologies Co., Ltd.